Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for ABO-incompatible Liver Transplantation
NCT02706132Phase 2Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in Liver transplant rejection, ischemic-type biliary lesions (ITBL), Primary graft non-function (PNF), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
Liver transplant rejectionischemic-type biliary lesions (ITBL)Primary graft non-function (PNF)
Beyond the preview
Go deeper on NCT02706132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706132.